Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus

AIM: The objective of this study was to assess if avibactam, a new β-lactamase inhibitor, can restore the potency of carbapenems, a sub-class of β-lactams, against Mycobacterium abscessus clinical isolates. MATERIALS & METHODS: 28 M. abscessus clinical isolates that are resistant to multiple dru...

全面介紹

Na minha lista:
書目詳細資料
發表在:Future Microbiol
Main Authors: Kaushik, Amit, Gupta, Chhavi, Fisher, Stefanie, Story-Roller, Elizabeth, Galanis, Christos, Parrish, Nicole, Lamichhane, Gyanu
格式: Artigo
語言:Inglês
出版: Future Medicine Ltd 2017
主題:
Short Communication
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5618940/
https://ncbi.nlm.nih.gov/pubmed/28326811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fmb-2016-0234
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍